Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.37 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.31 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9408109 | 0.78 | FFAR1 (0.39) | ALDH1A1TDP1TP53 | |
| SCHEMBL9408115 | 0.78 | FFAR1 (0.39) | ALDH1A1TDP1TP53 | |
| SCHEMBL15302687 | 0.78 | ALDH1A1 (0.65) | ALDH1A1TSHRTDP1HDAC8CHRNB2 | |
| SCHEMBL473081 | 0.76 | ALDH1A1 (1.00) | ALDH1A1TSHRTDP1HDAC8CHRNB2 | |
| SCHEMBL104811 | 0.76 | APP (0.32) | — | |
| SCHEMBL7639 | 0.76 | ALDH1A1 (1.00) | ALDH1A1TSHRTDP1HDAC8CHRNB2 | |
| SCHEMBL8767071 | 0.76 | ALDH1A1 (0.61) | ALDH1A1TSHRTDP1HDAC8CHRNB2 | |
| SCHEMBL369156 | 0.76 | CYP2A6 (0.48) | ALDH1A1 | |
| SCHEMBL6522801 | 0.74 | ALDH1A1 (0.58) | ALDH1A1TSHRTDP1HDAC8CHRNB2 | |
| SCHEMBL10029030 | 0.74 | ALDH1A1 (0.58) | ALDH1A1TSHRTDP1HDAC8TAS1R3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 202 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117899934-A | Chlorine-containing mildew amine organic porous polymer catalyst and synthetic method and application thereof | 上海理工大学 | 2024-04-19 | — | — | CN | claimed |
| US-20230100363-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | ORCA HOLDINGS, LLC | 2023-03-30 | — | — | US | claimed |
| US-20220177666-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | ORCA HOLDINGS, LLC | 2022-06-09 | — | — | US | claimed |
| EP-3938359-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | 6th Wave Innovations Corp. (US) | 2022-01-19 | — | — | EP | claimed |
| WO-2020186077-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | 6th Wave Innovations Corp. (US) | 2020-09-17 | — | — | WO | claimed |
| EP-3152573-B1 | METHOD FOR ANALYTICALLY CHECKING THE AUTHENTICITY OF INGREDIENTS IN FOODSTUFFS USING ARTIFICIAL ANTIBODIES | GFL GES FUER LEBENSMITTEL FORSCHUNG MBH (DE) | 2018-10-24 | — | — | EP | claimed |
| EP-3152573-A1 | METHOD FOR ANALYTICALLY CHECKING THE AUTHENTICITY OF INGREDIENTS IN FOODSTUFFS USING ARTIFICIAL ANTIBODIES | GFL Gesellschaft Für Lebensmittel-Forschung mbH (DE) | 2017-04-12 | — | — | EP | claimed |
| WO-2015185030-A1 | METHOD FOR ANALYTICALLY CHECKING THE AUTHENTICITY OF INGREDIENTS IN FOODSTUFFS USING ARTIFICIAL ANTIBODIES | GFL GESELLSCHAFT FÜR LEBENSMITTEL-FORSCHUNG MBH (DE) | 2015-12-10 | — | — | WO | claimed |
| EP-2149581-A1 | MONOMER AND COMPOSITION FOR PRODUCING LOW-PERCENTAGE HYDROGEL AND/OR HYDROGEL HAVING A LOW CROSS LINKAGE CONTENT, A HYDROGEL AND A BIOCHIP BASED THEREON | Institut Molekulyarnoi Biologii Im. V.A. Engelgardta Rossiiskoi Akademii Nauk (RU) | 2010-02-03 | — | — | EP | claimed |
| US-20040259182-A1 | Arrays for chemiluminescent assays, methods of making the arrays and methods of detecting chemiluminescent emissions on solid supports | APPLIED BIOSYSTEMS, LLC | 2004-12-23 | — | — | US | claimed |
| US-5622694-A | WATER OR ALCOHOL SOLUBLE | THE PROCTER & GAMBLE COMPANY (US) | 1997-04-22 | — | — | US | claimed |
| EP-0715638-A1 | SILICONE GRAFTED THERMOPLASTIC ELASTOMERIC COPOLYMERS AND HAIR AND SKIN CARE COMPOSITIONS CONTAINING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 1996-06-12 | — | — | EP | claimed |
| EP-0715637-A1 | SILICONE GRAFTED THERMOPLASTIC ELASTOMERIC COPOLYMERS AND HAIR AND SKIN CARE COMPOSITIONS CONTAINING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 1996-06-12 | — | — | EP | claimed |
| EP-0706537-A1 | THERMOPLASTIC ELASTOMERIC COPOLYMERS AND HAIR AND SKIN CARE COMPOSITIONS CONTAINING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 1996-04-17 | — | — | EP | claimed |
| WO-1996000562-A1 | PERSONAL CARE COMPOSITIONS CONTAINING THERMOPLASTIC ELASTOMERIC GRAFT COPOLYMERS | THE PROCTER & GAMBLE COMPANY (US) | 1996-01-11 | — | — | WO | claimed |
| WO-1995006079-A1 | SILICONE GRAFTED THERMOPLASTIC ELASTOMERIC COPOLYMERS AND HAIR AND SKIN CARE COMPOSITIONS CONTAINING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 1995-03-02 | — | — | WO | claimed |
| WO-1995006078-A1 | SILICONE GRAFTED THERMOPLASTIC ELASTOMERIC COPOLYMERS AND HAIR AND SKIN CARE COMPOSITIONS CONTAINING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 1995-03-02 | — | — | WO | claimed |
| WO-1995001384-A1 | THERMOPLASTIC ELASTOMERIC COPOLYMERS AND HAIR AND SKIN CARE COMPOSITIONS CONTAINING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 1995-01-12 | — | — | WO | claimed |
| US-4868241-A | POLYVINYL ALCOHOL MODIFIED WITH BENZOIC ACID DERIVATIVE | AMERICAN CYANAMID COMPANY (US) | 1989-09-19 | — | — | US | claimed |
| EP-0231922-A2 | Electron beam and X-ray resists | AMERICAN CYANAMID COMPANY (US) | 1987-08-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230100363-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | CNR2, CNR1, CDIPT | ALDH1A1 3487/4885TSHR 4448/4885TDP1 3652/4885 |
| US-20220177666-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | CNR2, CNR1, CDIPT | ALDH1A1 3487/4885TSHR 4448/4885TDP1 3652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.